http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2380335-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68c213ba9952360f439567152e047b18 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-93 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-00 |
filingDate | 2000-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc305c2fc08569b756ca8af22d06fa4e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b16828a0ee869e4f17fbf6a31d1625b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1e5697cd2a3c97409758e7a235db279 |
publicationDate | 2001-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2380335-A1 |
titleOfInvention | Use of the crystal structure of staphylococcus aureus isoleucyl-trna synthetase in antibiotic design |
abstract | The present invention provides the atomic coordinates derived from high resolution x-ray diffraction of the cocrystal complex comprising mupirocin with its target enzyme, isoleucyl-tRNA synthetase form Staphylococcus aureus , and the cognate tRNAile from Escherichia coli. The present invention further provides methods of using the atomic coordinates to identify and design new agents which modulate protein synthesis as well as the agents themselves.</S DOAB> |
priorityDate | 1999-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1135.